Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.

11/08/2019
/ Publications
/
Hypofractionation

A cohort of 146 patients with low-risk prostate cancer were treated to 60 Gy (cobalt Gy equivalent) of proton therapy (20 fractions of 3.0 Gy per fraction) in 4...

Proton therapy for non-small cell lung cancer: the road ahead.

11/09/2019
/ Publications

This latest review article examined the up-to-date clinical data of PBT for both early stage and locally advanced stage NSCLC. In particular, this review...

Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.

11/10/2019
/ Publications
/
Reirradiation

This retrospective study analyzing 16 patients with locally recurrent breast cancer who underwent re-irradiation to the chest wall with PBT to the median dose...

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.

11/07/2019
/ Publications
/
Toxicity
Reirradiation

Sixty-nine patients with sinonasal tumors underwent curative intent PBT including 42 patients received de novo irradiation and 27 received reirradiation. With...

Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.

07/07/2016
/ Publications

This study from Japan evaluated outcomes of PBT for locally recurrent parotid gland cancer. Ten patients were treated to 70.2 Gy equivalents in 32 fractions...

High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer.

11/12/2019
/ Publications
/
Hypofractionation

Perineural invasion (PNI) is an uncommon (5%) which refers to tumor cell invasion extensive enough to cause clinically detectable deficits of the involved...

Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.

07/07/2016
/ Publications
/
Survival

Based on the national cancer database, there were total of 175,088 patients with HNSCC receiving either photon or proton RT. This analysis pointed out that...

Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

11/11/2019
/ Publications
/
Toxicity

Hepatocellular carcinoma (HCC) with inferior vena cava tumor thrombus (IVCTT) is rare and regarded as an advanced disease stage with a poor prognosis. This...

Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.

11/11/2019
/ Publications
/
Toxicity
Survival
Chemotherapy

This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

11/12/2019
/ Publications
/
Hypofractionation
Survival

This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...